Impact of de-escalation on ICU patients’ prognosis

Intensive Care Medicine

Volumn 40, Issue 10, 2014, Pages 1583-1585

  De Waele, Jan J ^a   Bassetti, Matteo ^b   Martin Loeches, Ignacio ^c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CRITICALLY ILL PATIENT; DEESCALATION ANTIBIOTIC THERAPY; DISEASE SEVERITY; DRUG SAFETY; DRUG USE; EDITORIAL; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LUNG INFECTION; MORTALITY; PATHOGEN CLEARANCE; PRIMARY INFECTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUPERINFECTION; TREATMENT DURATION; FEMALE; MALE; SEPSIS; STATISTICS AND NUMERICAL DATA; TREATMENT WITHDRAWAL;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; LENGTH OF STAY; MALE; SEPSIS; WITHHOLDING TREATMENT;

EID: 84918769109     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-014-3488-0     Document Type: Editorial

References (10)

1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228
2. Rello J, Vidaur L, Sandiumenge A, Rodriguez A, Gualis B, Boque C, Diaz E (2004) De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 32:2183–2190
3. Kollef MH, Morrow LE, Niederman MS, Leeper KV, Anzueto A, Benz-Scott L, Rodino FJ (2006) Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 129:1210–1218
4. De Waele JJ, Ravyts M, Depuydt P, Blot SI, Decruyenaere J, Vogelaers D (2010) De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality? J Crit Care 25:641–646
5. Heenen S, Jacobs F, Vincent JL (2012) Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often? Crit Care Med 40:1404–1409
6. Montravers P, Dupont H, Gauzit R, Veber B, Bedos JP, Lepape A (2011) Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care 15:R17
7. Garnacho-Montero J, Gutierrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernandez-Delgado E, Herrera-Melero I, Ortiz-Leyba C, Marquez-Vacaro JA (2014) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 40:32–40
8. Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanese J, Jaber S, Lepape A, Constantin JM, Papazian L, Bruder N, Allaouchiche B, Bezulier K, Antonini F, Textoris J, Martin C (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med. doi:10.1007/s00134-014-3411-8
9. Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, Berger P, Duran S, Faucher M, Blache JL, Saillard C, Vey N, Leone M (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40:41–49
10. Martin-Loeches I, Diaz E, Valles J (2014) Risks for multidrug-resistant pathogens in the ICU. Curr Opin Crit Care 20:516–524